Navigation Links
Cancer research partnership between UCSF, MMRF to drive drug development
Date:5/29/2009

vering new treatment options to patients, multiple myeloma remains very difficult to treat and effective treatment options are limited," said Wolf. "By bringing to bear the expertise of UCSF in partnership with the MMRF, we are confident that the MMTI will hasten the pace at which new therapies to treat the disease are developed."

UCSF is at the forefront in advancing translational research, which is recognized as the critical weak link in medical science today. It involves moving discoveries made in the lab through the process of animal studies, animal testing and small-scale human trials to determine if a discovery warrants examination on a larger scale by a biotechnology or pharmaceutical company.

Research universities have excelled at discovering the genes and proteins and other cellular and extracellular components that underlie disease processes, but they have not had the infrastructure to investigate the potential of these components as therapeutic targets or tools. The work requires close collaboration between basic researchers, clinical researchers and clinicians.

In 2006, UCSF received a five-year, $100 million grant from the National Institutes of Health to support further development of the UCSF infrastructure for translational medicine. UCSF's existing infrastructure will enable the MMTI to begin its research efforts immediately.

"Currently, there are few translational research initiatives focused solely on multiple myeloma, so we are especially proud to support the MMRF and UCSF, and we are grateful to HHMI for its help in supporting such exciting, important science," said Stephen Grand, an MMRF board member. "The MMTI provides new hope for patients whose treatment options are limited, by enabling the swifter development of new drug candidates and increasing access to promising therapies under investigation."


'/>"/>

Contact: Jennifer OBrien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancer
2. Falcon Genomics Awarded Patent for Innovative Cancer Test
3. Cancer cells need normal, nonmutated genes to survive
4. The vulnerable cancer cell
5. New survey highlights growing concern about risk of infection in cancer patients
6. Cancer Survivors Can Still Be Fit, Study Asserts
7. New blood test greatly reduces false-positives in prostate cancer screening
8. Cardiovascular fitness not affected by cancer treatment
9. Cottonseed-based drug shows promise in treating severe brain cancer
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... The short film “Color of Honor” by young director/producer ... true 9/11 hero, Welles Remy Crowther. It has been chosen ... of Nuremberg International Short Film Festival and the 8th International ... and director Luciana Lagana plays the mother of the ... Gregory Graham - Graham plays a heroic policeman ...
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International ... after an 8 year battle with breast cancer. ... in her home in Woodland Hills California after an ... , As the founder and volunteer President ... and championed many of today's greatest breakthroughs in restoring ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... illnesses can receive effective, less expensive care from a clinic ... a team of dedicated health care professionals, a new study ... and need either hospitalization or a trip to the emergency ... clinic at the University of Texas in Houston versus usual ...
(Date:12/25/2014)... early stage breast cancer patients who undergo chemotherapy and/or ... eventually develop leukemia as a result of their treatment, ... a review of more than 20,000 breast cancer cases ... the risk for developing treatment-related leukemia, though low, is ... frequency of bone marrow cancers such as leukemia is ...
(Date:12/25/2014)... 2014 Thousands of transvaginal mesh lawsuits ... a number of multidistrict litigations currently underway in U.S. ... LLP reports. According to an Order issued on December ... Joint Status Conference in all of the proceedings on ... directed to submit a proposed agenda to the Court ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... first intention molecule for the treatment of epilepsy in ... to an irreversible loss of vision. Serge Picaud, head ... Institut de la Vision have just discovered the origin ... limiting it. They have shown that vigabatrin provokes a ...
... of Medicine is convening the Summit on Integrative Medicine ... science, understanding, and progress of integrative medicine and explore ... the nation,s health care crisis. , Integrative medicine is ... patients and caregivers in the full range of physical, ...
... drive adoption DALLAS, Feb. 17 Providers of ... and personal health records (PHR) can generate over ... the disease management (DM) industry, according to Parks ... High-Tech Adoption . The international research firm cites ...
... Angeles Jewish Home are in it for the , Long ... Feb. 17 At the Los Angeles Jewish Home, one ... roof in the U.S. all agree on two things: They ... have the best ideas on just how to accomplish that ...
... have discovered that estrogen receptors are present in ... them to believe that anti-estrogen drug treatments may ... patients, overall outcome. , This research is being ... Endocrinology . , In estrogen-responsive cancerssuch as breast ...
... at The Medical College of Wisconsin in Milwaukee have linked ... and blood vessel disease in African Americans. Aldosterone is secreted ... kidneys. , The study appeared in the December 18, ... prevalence of high blood pressure, or hypertension, in African Americans ...
Cached Medicine News:Health News:Taurine: Key to the visual toxicity of an anti-epileptic drug for children? 2Health News:Taurine: Key to the visual toxicity of an anti-epileptic drug for children? 3Health News:IOM convenes Feb. 25-27 Summit on Integrative Medicine 2Health News:Personal Health Technology Spending to Exceed $460 Million in the Disease Management Sector in 2013 2Health News:Unique Group of 90-Year-Olds Share Top Ten Longevity Tips 2Health News:Unique Group of 90-Year-Olds Share Top Ten Longevity Tips 3Health News:Estrogen found to increase growth of the most common childhood brain tumor 2
(Date:12/24/2014)... and FARMINGTON, Conn. , ... (NYSE MKT: PTN), a biopharmaceutical company developing targeted, ... with significant unmet medical need and commercial potential, ... private placement of 2,050,000 shares of its common ... shares of its common stock.  Funds under the ...
(Date:12/24/2014)... DIEGO , Dec. 23, 2014 ResMed (NYSE: ... significant patent infringement action against Chinese medical device manufacturer BMC ... (ITC) ruled today that BMC,s masks listed below infringe ResMed,s ... or selling these masks in the United States ... iVolve N2 nasal mask , Willow nasal pillows mask ...
(Date:12/24/2014)... 2014  The American Diabetes Association is recommending ... people with diabetes and that all people with ... statins, in keeping with recent changes to guidelines ... College of Cardiology (ACC) and American Heart Association ... recent changes to the Association,s annual revised Standards ...
Breaking Medicine Technology:Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: